|
Sign In to gain access to subscriptions and/or personal tools.
|
Pathological involvement of chymase-dependent angiotensin II formation in the development of cardiovascular disease
Hidenori Urata
Department of Internal Medicine , Fukuoka University, School of Medicine, Fukuoka, Japan, uratah{at}fukuoka-u.ac.jp
Chymase is a potent and specific angiotensin II (Ang II)-forming enzyme in vitro. There is also strong evidence to suggest its importance in vivo. Recent clinical studies have suggested that high serum cholesterol levels are associated with increased vascular chymase activity and this may assist in the development of atherosclerosis. This clinical finding has been reproduced in hamster models. Studies with transgenic mice overexpressing the human chymase gene suggest a direct association between vascular chymase upregulation and atherogenesis. There is also increased chymase activity following various cardiac diseases such as myocardial ischaemia, volume overload cardiac failure, cardiomyopathy and viral myocarditis, suggesting that increased cardiac chymase activity appears to be involved in cardiac remodelling.
Key Words: chymase heart failure animal model atherosclerosis angiotensin II Ang II receptor blocker cardiac remodelling
References
- Wei CC, Meng QC, Palmer R. et al. Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart In vivo. Circulation 1999;99:2583-9.[Abstract/Free Full Text]
- Wolny A., Clozel JP, Rein J. et al. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res 1997;80:219-27.[Abstract/Free Full Text]
- Urata H., Healy B., Stewart RW, Bumpus FM, Husain A.: Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990;66:883-90.[Abstract/Free Full Text]
- Urata H., Kinoshita A., Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990;265:22348-57.[Abstract/Free Full Text]
- Urata H., KinoshitaA, Perez DM et al. Cloning of the gene and cDNA for human heart chymase. J Biol Chem 1991;266:17173-9.[Abstract/Free Full Text]
- Urata H., Boehm KD, PhilipA. et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993;91:1269-81.[Web of Science][Medline]
[Order article via Infotrieve]
- Rousseau MF, Kostam MA, Benedict CR et al. Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor.AmJCardiol 1994;73:488-93.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ihara M., Urata H., Kinoshita A. et al. Angiotensin II-forming activity and its responsible enzyme in acute myocardial infarction. Jpn Circ J 1998;62(Suppl I):468.
- Dell'Italia LJ, Meng QC, Balcells E. et al. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am J Physiol 1995;269:H2065-H2073.[Web of Science][Medline]
[Order article via Infotrieve]
- Akasu M., Urata H., Kinoshita A., Sasaguri M., Ideishi M., Arakawa K. Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension 1998;32:514-20.[Abstract/Free Full Text]
- Shiota N., Fukamizu A., Takai S., Okunishi H., Murakami K., Miyazaki M. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart. J Hypertens 1997;15:431-40.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hirakata H., Fouad-Tarazi FM, Bumpus FM et al. Angiotensins and the failing heart: enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril. Circ Res 1990;66:891-9.[Abstract/Free Full Text]
- Nakayama S., Uehara Y., Urata H. et al. Differential regulation of angiotensin II-forming enzymes by tissues in 2-kidney 1 clip hypertensive hamster. J Hypertens 1998;16(Suppl 2):S124.
- Arakawa K., Urata H. Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis.Hypertension 2000;36:638-41.[Abstract/Free Full Text]
- Ihara M., Urata H., Kinoshita A. et al. Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 1999;33:1399-405.[Abstract/Free Full Text]
- Uehara Y., Urata H., Sasaguri M. et al. Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia.Hypertension 2000;35:55-60.[Abstract/Free Full Text]
- Uehara Y., Urata H., KogaT., Okamoto T., Ideishi M.,Arakawa K. Chymase inhibitor decrease aortic cholesterol deposition in high cholesterol-fed hamster. Circulation 1999;100(Suppl I):I-473.
- Koga T., Urata H., Matsunaga A., Sasaki J., Ideishi M., Arakawa K. Human chymase overexpression in mice induces weight loss, hypocholesterolemia, leukocytosis and tachycardia. Circulation 1999;100(Suppl I):I-813.
Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 2 suppl,
S35-S37 (2000)
DOI: 10.3317/jraas.2000.054

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|